Adiponectin, exhibiting antihyperglycemic, antiatherogenic, and anti-inflammatory properties, could have important clinical benefits in terms of development of therapies for the prevention and/or for the treatment of obesity and obesity-related diseases. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.